<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors></authors><secondary-authors><author><style face="normal" font="default" size="100%">Fonarow, Gregg</style></author><author><style face="normal" font="default" size="100%">Redfield, Margaret M.</style></author><author><style face="normal" font="default" size="100%">Goldberg, Lee</style></author><author><style face="normal" font="default" size="100%">Drazner, Mark</style></author><author><style face="normal" font="default" size="100%">Rogers, Joseph G.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Modern Management of Chronic Heart Failure: From Stage a to Stage D and beyond</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2006</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2006-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">25-25</style></pages><abstract><style  face="normal" font="default" size="100%">Gregg Fonarow, MD, Division of Cardiology, University of California, agreed. “There are many patients without evidence of structural heart disease who are at increased risk,” he said. “And the data shows that modification of risk factors can have enormous impact in mitigating disease.”</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">6</style></volume></record></records></xml>